Allergy and Asthma

Part 1 Lipid mediators and their antagonists: the future promise of agents which inhibit the formation and action of lipidmediators; agents which inhibit the 5-lipoxygenase and cycloxygebase pathways and their relationship to the treatment of allergic responses; leukotriene inhibitors and antagonists in asthma; platelet activing factor and biologically active acetylated phospholipids in asthma; pharmacological modulation of mediator generation and the allergic response by fish-oil diets; general discussion. Part 2 Modulating the specific immune response: prospects for modulation of the specific immune response in allergic diseases; new ideas on the preventions of allergy; suppression of the IgE response with human proteins developed by biotechnology; immunotherapy of asthma; general discussion. Part 3 Agents which supress inflammation: antiinflammatory agents in the treatment of bronchial asthma; nedocromil sodium - a review of its anti-inflammatory properties and critical activity in the treatment of asthma; cetizirene - a new selective H1-antagonist with effects on infiltrating inflammatory cells; lipocortinazelastine - a novel oral antiasthma compound with several modes of action; general discussion. Part 4 Concluding remarks: summing-up and general discussion.